Health Cana­da is­sues two re­calls for Pfiz­er blood pres­sure drugs over im­pu­ri­ty

Last year, Pfiz­er stopped dis­tri­b­u­tion of megablock­buster smok­ing ces­sa­tion drug Chan­tix over an in­creased lev­el of car­cino­genic ni­trosamines.

Now, two of the Big Phar­ma’s blood …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.